Related Experiment Videos
Stroke in children
S G Pavlakis1, R J Gould, J L Zito
1Cornell University Medical College, Department of Neurology, New York, New York.
Insights
Childhood stroke evaluation and treatment require special considerations due to unique causes and limited drug therapies. Interventions like anticoagulation and surgery for vascular malformations and aneurysms are carefully chosen based on the child
Area of Science:
- Pediatric Neurology
- Vascular Medicine
- Genetics
Background:
- Childhood stroke shares similarities with adult stroke but is often linked to congenital and genetic factors.
- The management of pediatric stroke presents unique challenges due to developmental considerations and limited evidence-based drug therapies.
- Current therapeutic interventions for childhood stroke are often problematic and require careful consideration.
Purpose of the Study:
- To highlight the special considerations required for the evaluation and treatment of children experiencing stroke.
- To discuss the current limitations and potential roles of various therapeutic interventions in pediatric stroke management.
- To emphasize the need for improved diagnostic tools and treatment strategies in childhood stroke.
Main Methods:
- Review of existing literature on pediatric stroke etiology, evaluation, and treatment.
- Discussion of pharmacological interventions, including platelet antagonists and anticoagulation (warfarin).
- Analysis of surgical and alternative therapies for vascular malformations and aneurysms.
- Consideration of newer imaging modalities for pathophysiologic clarification.
Main Results:
- Platelet antagonists are considered rational prophylactic options.
- Warfarin may play a role in preventing cardiogenic emboli in older children.
- Chronic anticoagulation is relatively contraindicated in toddlers due to trauma risks.
- Surgical repair is standard for vascular malformations, with radiation and embolization as alternatives for inoperable cases.
- Aneurysms are primarily treated surgically.
Conclusions:
- The management of childhood stroke necessitates a tailored approach, considering the child's specific condition and age.
- Therapeutic decisions, particularly regarding anticoagulation, must weigh risks and benefits carefully.
- Advancements in imaging technologies are expected to improve the understanding and treatment of pediatric stroke.
Abstract:
Childhood stroke, although similar to adult stroke, is characterized by congenital and genetic causes. The evaluation and treatment of the child with stroke requires special considerations. Currently, drug therapy is untested and as a result, therapeutic interventions are problematic. Platelet antagonists are rational prophylactically; warfarin probably has a role in preventing cardiogenic embolus in the older child. However, chronic anticoagulation in the toddler is dangerous due to frequent trauma and is therefore relatively contraindicated. Vascular malformations are surgically repaired but alternative therapies, including radiation and embolization, may be used for inoperable lesions. Aneurysms are primarily surgical lesions. Newer imaging modalities will clarify the pathophysiologic picture and improve treatment.